Insider Trading & Ownership - OrbiMed Advisors III Ltd

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for OrbiMed Advisors III Ltd
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-12-23
Purchase
2022-12-28
5:57 pm
Terns Pharmaceuticals Inc.TERNORBIMED ADVISORS LLC
OrbiMed Capital GP VII LLC
OrbiMed Asia GP III L.P.
OrbiMed Advisors III Ltd
OrbiMed Genesis GP LLC
Director
10% Owner
137,931$7.25$1,000,0007,619,135
(Indirect)
View
2022-08-16
Purchase
2022-08-18
5:00 pm
Terns Pharmaceuticals Inc.TERNORBIMED ADVISORS LLC
OrbiMed Capital GP VII LLC
OrbiMed Asia GP III L.P.
OrbiMed Advisors III Ltd
OrbiMed Genesis GP LLC
Director
10% Owner
3,690,000$2.42$8,929,8001,072,400
(Indirect)
View
2021-02-09
Purchase
2021-02-09
3:09 pm
Terns Pharmaceuticals Inc.TERNORBIMED ADVISORS LLC
OrbiMed Capital GP VII LLC
OrbiMed Asia GP III L.P.
OrbiMed Advisors III Ltd
Director
10% Owner
475,000$17$8,075,0002,274,723
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2021-02-09
Conversion
2021-02-09
3:09 pm
N/A
N/A
Terns Pharmaceuticals Inc.TERNORBIMED ADVISORS LLC
OrbiMed Capital GP VII LLC
OrbiMed Asia GP III L.P.
OrbiMed Advisors III Ltd
Director
10% Owner
6,632,408$02,274,723
(Indirect)
View

Ownership
2021-02-04
5:07 pm
N/A
N/A
Terns Pharmaceuticals Inc.TERNORBIMED ADVISORS LLC
OrbiMed Capital GP VII LLC
OrbiMed Asia GP III L.P.
OrbiMed Advisors III Ltd
Director
10% Owner
0$03,316,204
(Indirect)
View